However, inconsistent formulations and the lack of FDA approval raise important concerns regarding safety and reliability
Body Mass Index equal to or greater than 35 with at least two of the following comorbidities
S., Bogler, T., & Maxwell, C
Issued March 2009 Distributed by: MERCK & CO., INC., Whitehouse Station, NJ 08889, USA Last Updated: 03/09 Janumet, Sitagliptin and Metformin Hydrochloride, Patient Information (in plain English) Detailed Info on Signs, Symptoms, Causes, Treatments of Diabetes The information in this monograph is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects
Oxidants, inflammation, and anti-inflammatory drugs